TechniScan Secures Patent on Imaging Method for Breakthrough 3-D Breast Ultrasound

Thursday, May 6, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+



SALT LAKE CITY, May 6 TechniScan, Inc., (OTC Bulletin Board: TSNI) the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

The patent titled "Apparatus and Method for Imaging Objects with Wave Fields" outlines how the company's groundbreaking algorithms are translated into a high resolution, 3-D ultrasound image of the human breast. The patent also includes recursive methods for increasing the speed that the images are processed, which may deliver faster clinical outcomes for women awaiting breast-imaging results.

"This patent is another example of the deep portfolio of unique IP (intellectual property) that has resulted from our 20 years of research in the fields of mathematics and physics. The patent is a result of extensive work by our entire team to extract the benefits of complex transmission wave field imaging methods," said Dave Robinson, chief executive officer at TechniScan.

The science developed at TechniScan, Inc. has led to new ways of utilizing whole breast ultrasound technology that may more accurately distinguish pathological from normal breast tissue. The images are captured using a comfortable, radiation-free method as a woman lies prone on an examination table and ultrasound is directed, using warm water as a coupling medium, through her breast tissue.

About TechniScan, Inc.

Based in Salt Lake City, TechniScan, Inc. is a medical device company engaged in the development and commercialization of a non-invasive imaging tool designed to provide physicians with automated ultrasound images of the human breast. The system uses a process called Warm Bath Ultrasound (WBU(TM)) to provide automated, 3-D, ultrasound images of the physical structures within the breast. TechniScan's WBU(TM) imaging device is limited by U.S. law to investigational use unless, and until, cleared by the FDA. For more information, please visit www.techniscanmedical.com.

Press Contact: Tracy Harden, 801-994-2968, [email protected] Investment Banking Contact: Mark Diamond, Jesup & Lamont Securities Corp., 212-918-0415, [email protected]

SOURCE TechniScan, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store